Avicanna Inc. ( AVCNF) - Key Metrics
AVCNF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q1 | $0.06 | $0 | -$0.01 | -$0.01 |
| 2025Q4 | $0.06 | -$0.01 | $0 | $0 |
| 2025Q3 | $0.06 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q2 | $0.05 | -$0.01 | $0 | $0 |
AVCNF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.98 |
| 2026Q1 | 0% | -8.48 |
| 2025Q4 | 0% | -7.13 |
| 2025Q3 | 0% | -5.43 |
| 2025Q2 | 0% | -10.71 |
AVCNF
Price: $0.07
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -6.85
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 8.9 million